 - Treatment with long-acting β2-agonists LABA and inhaled corticosteroids ICS at a dose of at least 1000 μg beclomethasone or equivalent per day, - chronic oral corticosteroid OCS use is allowed Stable asthma medication for 1 month prior to screening 4 months for omalizumab 